Outcome Sciences,
Inc. today announced that the
Agency for Healthcare Research and Quality
(AHRQ) has published the second edition of, “Registries for Evaluating Patient Outcomes: A User’s Guide,” a Federal publication that provides information on designing, implementing, and evaluating patient registries.
The second edition of the User’s Guide, which reflects the work of more than 80 contributors from government, academic and private sectors, includes:
* New methodological developments;
* Emerging topics in registry science, including updates on safety;
* Technological advances; and
* Operational examples and case studies from around the world.
Updates to the original 11 chapters from the 2007 version of the handbook are included, as well as four new sections:
* Use of Registries in Product Safety Assessment
* Planning for the End of a Patient Registry
* Interfacing Registries and EHRs
* Linking Registry Data
OUTCOME was selected by AHRQ in 2005 to lead the effort to create the patient registries guide. OUTCOME’s Drs. Richard Gliklich and Nancy Dreyer served as the guide’s senior editors and authors for several chapters. The second edition includes 38 case studies, which illustrate real-life challenges in the design and conduct of registries. Contributors came from industry, academia, and government, with representation from various agencies in the U.S., as well as the National Institute for Health and Clinical Excellence in the U.K. The work was performed under contract to OUTCOME through its role as an AHRQ DEcIDE Research Center, a component of AHRQ’s Effective Health Care Program.
The guide will be available in on AHRQ’s website (
www.effectivehealthcare.ahrq.gov
) and will also be available in print.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.